Translational epidemiology is the study of risk factors and disease in large populations, harnessing the power of modern phenotyping, including large-scale “omics” approaches. In this review, we comment on the power and limitations of modern molecular translational epidemiology and suggest collaborative team science as a specific avenue to secure its existence in the next era of genomic research.
Keywords: genomics; metabolomics; research; risk factors; science.